Figure 6
From: APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
APR-246 resensitized the A2780-CP20 (a) and OVCAR-3 cells (b) to doxorubicin. The FMCA was used for measurement of cell viability. The values are mean±S.E.M. (n=2)
